Red Door Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
Red Door Wealth Management's MRNA Position: Q3 2021 in Review
Red Door Wealth Management sold out of Moderna (MRNA) in Q3 2021, closing a stake of 152 shares — an estimated $35K sold.
Red Door Wealth Management first reported a position in MRNA in Q2 2020 and held it in 2 quarters. The position peaked at $35K in Q2 2021. 1,140 funds tracked by Wall St. Rank hold MRNA as of Q3 2021.
- Red Door Wealth Management reported no remaining Moderna position as of Q3 2021 after selling out during the quarter.
- Red Door Wealth Management sold 152 Moderna shares in Q3 2021, an estimated $35K.
- Red Door Wealth Management first reported a position in Moderna in Q2 2020 and held it in 2 quarters.
- Red Door Wealth Management's Moderna position peaked at $35K in Q2 2021.
- 1,140 funds tracked by Wall St. Rank held Moderna as of Q3 2021.
Based on Red Door Wealth Management's 13F filing for Q3 2021, filed 14 Oct 2021.